Sprott Inc’s Allergan plc AGN Stock Holding History

Sprott Inc’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-7,998	Closed	-$1.94M	–	177
2017 Q2	$1.94M	Buy	7,998 +600	+8%	+$141K	0.07%	98
2017 Q1	$1.77M	Buy	7,398 +925	+14%	+$215K	0.07%	107
2016 Q4	$1.36M	Buy	+6,473	New	+$1.34M	0.12%	106

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Sprott Inc's AGN Position: Q3 2017 in Review

Sprott Inc sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 7,998 shares — an estimated $1.94M sold.

Sprott Inc first reported a position in AGN in Q4 2016 and held it in 3 quarters. The position peaked at $1.94M in Q2 2017. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

Sprott Inc reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
Sprott Inc sold 7,998 Allergan plc shares in Q3 2017, an estimated $1.94M.
Sprott Inc first reported a position in Allergan plc in Q4 2016 and held it in 3 quarters.
Sprott Inc's Allergan plc position peaked at $1.94M in Q2 2017.
1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Sprott Inc's 13F filing for Q3 2017, filed 3 Nov 2017.